Applied Pharmaceutical Analysis 2018

Save the Date for the 14th Annual APA Meeting!
October 1-3, 2018

Short Courses September 30th

Sheraton Boston Hotel 
39 Dalton Street 
Boston, MA 02199

APA 2018 Plenary Speakers

		Donna Dambach, VMD, PhD, Senior Director, Head of Toxicology, Safety Assessment, Genentech preclinical safety in drug discovery and development - Title to be announced
		Binodh DeSilva, PhD, Head of Analytical Strategy & Operations, Product Development The Impact of a Reagent Center of Excellence on Bioanalysis, and a Company’s Strategy around Variabilization
		Richard Smith, PhD, Batelle Fellow and Director of Proteome Research, Pacific Northwest National Laboratory New Developments in Ion Mobility-Mass Spectrometry Enabling Improved Higher Throughput and More Sensitive Proteomics and Pan-Omics Measurements for Clinical Diagnostics and Personalized Medicine

APA 2018 Confirmed Speakers

		William Gerwick, PhD, Distinguished Professor of Oceanography and Pharmaceutical Sciences, Director, Center for Marine Biotechnology and Biomedicine, Director, NIH Training Grant on Marine Biotechnology, Co-Director, UC San Diego Center for Compound Resources, Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego Antiparasitic Drug Discovery from Marine Cyanobacteria
		Sadik Kassim, PhD, Vice President, Process and Analytical Development, Mustang Bio CAR-T Therapy - Title to be announced
		Jochem Gokemeijer, PhD, Associate Director, Bristol-Myers Squibb ADA - Title to be announced
		Vibha Jawa, PhD, Director Biologics and Vaccine Development, Merck ADA - Title to be announced
		Christopher Kochansky, PhD, Associate Principal Scientist, Merck mass metasite/webmetabase for metabolite ID of small molecules and peptides - Title to be announced
		Jonathan Bauman, Principal Scientist, Pfizer Title to be announced

Invited Speakers:

Michael F. Skelly, Ph.D., Lead Pharmacologist, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Study Integrity and Surveillance, U.S. Food and Drug Administration

Arindam Dasgupta, PhD, Deputy Director, Division of New Drug Bioequivalence, OSIS, OTS, CDER, FDA

Proposed Sessions for APA 2018 Workshops 

Regulated Bioanalysis

Regulatory Session / Guidance

Challenges of Immunotherapy in a Regulated Environment

Bioanalytical Support for Novel Therapies

Miscellaneous Topics in Bioanalysis

New Technologies and Applications

Discovery Bioanalysis and New Technologies

Anti-Drug Antibodies (ADA)

Information Technology - Knowledge Management

New Technologies

Omics

Mechanistic ADME

Unusual Metabolites

Toxicity/Safety

Speciality Molecules: Going Beyond the Rule of 5

Software for Met ID

Combined Mechanistic Adme and Discovery Bioanalysis

Role of DMPK in New Modalities

Exploratory Biomarker Analysis

Beyond ADME and Bioanalysis

NASH

CNS

Global Health

Rare/Neglected Diseases

Novel Drug Delivery Systems